Thus, data from human HCC and specifically from S2 molecular HCC subclass largely support experimental findings on GPx4 impact on cell proliferation, cytokine release, angiogenesis and immune cell infiltration. The gene discussed is GPX4; the disease is hepatocellular carcinoma.